Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 453-455

  Minami, Rumiko ^a   Nakamura, Chizuko ^a   Inotsume, Nobuo ^a,b   Nakano, Masahiro ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOSUFLOXACIN TOSILATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MIXTURE; DRUG URINE LEVEL; GRAM NEGATIVE INFECTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; ALUMINUM HYDROXIDE; ANTACIDS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; BIOLOGICAL AVAILABILITY; DRUG INTERACTIONS; FAMOTIDINE; FLUOROQUINOLONES; HUMANS; MALE; NAPHTHYRIDINES;

EID: 0031891283     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Fujimaki, K., T. Noumi, Y. Hamana, S. Mitsuhashi, and M. Inoue. 1988. Antibacterial activity of T-3262. Chemotherapy 36(Suppl. 9):1-18.
2. Granneman, G. R., U. Stephan, B. Birner, F. Sörgel, and D. Mukherjee. 1992. Effect of antacid medication on the pharmacokinetics of temafloxacin. Clin. Pharmacokinet. 22(Suppl. 1):83-89.
3. Lehto, P., and K. T. Kivistö. 1994. Different effects of products containing metal ions on the absorption of lomefloxacin. Clin. Pharmacol. Ther. 56: 477-482.
4. Lehto, P., K. T. Kivistö, and P. J. Neuvonen. 1994. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin. Br. J. Clin. Pharmacol. 37:82-85.
5. Nakano, M., M. Yamamoto, and T. Arita. 1978. Interactions of aluminum, magnesium, and calcium ions with nalidixic acid. Chem. Pharm. Bull. 26: 1505-1510.
6. Nakashima, M., T. Uematsu, M. Kanamaru, T. Yasuda, Y. Watanabe, and M. Tai. 1988. Phase I study of T-3262, a new pyridonecarboxylic acid derivative. Chemotherapy 36(Suppl. 9):158-180.
7. Nix, D. E., W. A. Watson, M. E. Lener, R. W. Frost, G. Krol, H. Goldstein, J. Lettieri, and J. J. Schentag. 1989. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin. Pharmacol. Ther. 46:700-705.
8. Petring, O. U., B. Adelhi, M. Ibsen, and H. E. Poulsen. 1986. The relationship between gastric emptying of semisolids and paracetamol absorption. Br. J. Clin. Pharmacol. 22:659-662.
9. Shiba, K., A. Saito, T. Miyahara, H. Tachizawa, and T. Fujimoto. 1988. Effect of aluminum hydroxide, an antacid, on the pharmacokinetics of new quinolones in humans. Xenobiot. Metab. Dispos. 3:717-722.
10. Shimada, J., K. Shiba, T. Oguma, H. Miwa, Y. Yoshimura, T. Nishikawa, Y. Okabayashi, T. Kitayasu, and S. Yamamoto. 1992. Effect of antacid on absorption of the quinolone lomefloxacin. Antimicrob. Agents Chemother. 36:1219-1224.
11. Tai, M., Y. Sugimoto, Y. Katayama, and T. Maeda. 1988. Phase I study on T-3262 metabolites in serum, urine and feces. Chemotherapy 36(Suppl. 9):208-215.
12. Yamaoka, K., Y. Tanigawara, T. Nakagawa, and T. Uno. 1981. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:879-885.
13. Yasuda, T., Y. Watanabe, S. Minami, K. Kumano, R. Tsuneda, and J. Kanayama. 1988. Microbiological assay method for T-3262 concentration in body fluids. Chemotherapy 36(Suppl. 9):137-142.